Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew P Schachat

Showing results (1-10 of 116) with videos related to

Pageof 12
Sort By:
Ophthalmology. Retina|July 7, 2019
Quality ImprovementAndrew P Schachat
Ophthalmology|September 3, 2008
A new look at an old treatment for diabetic macular edemaAndrew P Schachat
American Journal of Ophthalmology|June 25, 2013
Switching anti-vascular endothelial growth factor therapy for neovascular age-related macular degenerationAndrew P Schachat
Ophthalmology|February 27, 2019
If There Is Loss to Follow Up, Poor Outcomes May Be More Common after Anti-Vascular Endothelial Growth Factor Treatment for Diabetic RetinopathyAndrew P Schachat
Ophthalmology. Retina|May 4, 2019
Real-World Papers, Prophylaxis for Intravitreal Injections, Fluorescein Angiography and Neovascular Age-Related Macular Degeneration, and Anti-Vascular Endothelial Growth Factor SafetyAndrew P Schachat
Ophthalmology|June 5, 2010
A new approach to the management of diabetic macular edemaAndrew P Schachat
Ophthalmology|January 4, 2003
Three tough acts to follow and the watch changes. Now, what?Andrew P Schachat
Ophthalmology|April 6, 2005
New treatments for age-related macular degenerationAndrew P Schachat
American Journal of Ophthalmology|March 28, 2007
Peers review, editors decide, and then, what?Andrew P Schachat
Ophthalmology|June 12, 2003
What is HIPAA and what effect may it have on our journal?Andrew P Schachat
Pageof 12

Showing results (1-10 of 116) with videos related to

Sort By:
Pageof 12
Ophthalmology. Retina|July 7, 2019
Quality ImprovementAndrew P Schachat
Ophthalmology|September 3, 2008
A new look at an old treatment for diabetic macular edemaAndrew P Schachat
American Journal of Ophthalmology|June 25, 2013
Switching anti-vascular endothelial growth factor therapy for neovascular age-related macular degenerationAndrew P Schachat
Ophthalmology|February 27, 2019
If There Is Loss to Follow Up, Poor Outcomes May Be More Common after Anti-Vascular Endothelial Growth Factor Treatment for Diabetic RetinopathyAndrew P Schachat
Ophthalmology. Retina|May 4, 2019
Real-World Papers, Prophylaxis for Intravitreal Injections, Fluorescein Angiography and Neovascular Age-Related Macular Degeneration, and Anti-Vascular Endothelial Growth Factor SafetyAndrew P Schachat
Ophthalmology|June 5, 2010
A new approach to the management of diabetic macular edemaAndrew P Schachat
Ophthalmology|January 4, 2003
Three tough acts to follow and the watch changes. Now, what?Andrew P Schachat
Ophthalmology|April 6, 2005
New treatments for age-related macular degenerationAndrew P Schachat
American Journal of Ophthalmology|March 28, 2007
Peers review, editors decide, and then, what?Andrew P Schachat
Ophthalmology|June 12, 2003
What is HIPAA and what effect may it have on our journal?Andrew P Schachat
Pageof 12